---
figid: PMC7648632__41419_2020_3140_Fig1_HTML
figtitle: PD-L1 degradation pathway and immunotherapy for cancer
organisms:
- Homo sapiens
pmcid: PMC7648632
filename: 41419_2020_3140_Fig1_HTML.jpg
figlink: pmc/articles/PMC7648632/figure/Fig1/
number: F1
caption: PD-L1 undergoes ubiquitination and degradation by E3 ubiquitin ligases, including
  STUB1, Cullin3SPOP, and β-TrCP, which is abolished by CMTM4/6, CSN5, and STT3. Although
  glycosylation of PD-L1 increases its protein stability, the AMPK agonist or EGFR
  inhibitor reverses this process and induces PD-L1 proteasome-dependent degradation.
  Moreover, in response to extracellular stimuli, PD-L1 protein triggers ubiquitination
  and degradation by multiple pathways.
papertitle: PD-L1 degradation pathway and immunotherapy for cancer.
reftext: Qian Gou, et al. Cell Death Dis. 2020 Nov;11(11):955.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9370489
figid_alias: PMC7648632__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7648632__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7648632__41419_2020_3140_Fig1_HTML.html
  '@type': Dataset
  description: PD-L1 undergoes ubiquitination and degradation by E3 ubiquitin ligases,
    including STUB1, Cullin3SPOP, and β-TrCP, which is abolished by CMTM4/6, CSN5,
    and STT3. Although glycosylation of PD-L1 increases its protein stability, the
    AMPK agonist or EGFR inhibitor reverses this process and induces PD-L1 proteasome-dependent
    degradation. Moreover, in response to extracellular stimuli, PD-L1 protein triggers
    ubiquitination and degradation by multiple pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - SPOP
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CDK6
  - CDK4
  - CD274
  - ITK
  - SLC22A3
  - COPS5
  - CDH1
  - FZR1
  - CTNNB1
  - TCF4
  - TCF7L2
  - STT3A
  - STT3B
  - BTRC
  - GSK3B
  - EGFR
  - ATM
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - CMTM4
  - CMTM6
  - TNFRSF1A
  - Etoposide
  - Curcumin
  - Metformin
  - Cisplatin
---
